← Browse by Condition
Medical Condition
chronic myeloid leukemia chronic phase
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 2
NCT06119269
Recruiting
Ponatinib in Chronic Myeloid Leukemia Patients in Chronic Phase
Enrollment
100 pts
Location
Italy
Sponsor
University of Pisa
NCT05143840 Phase 2
Recruiting
Asciminib as Initial Therapy for Patients With Chronic Myeloid Leukemia in Chronic Phase
Enrollment
100 pts
Location
United States
Sponsor
Augusta University